Shota Kato

15PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GenomicsCancer geneticsHaematological tumoursNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 30, 2026
Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24).

|Jul 17, 2026
Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

|Apr 09, 2026
Phenotypic Expansion and Molecular Implications in Recessive FUZ -Related Ciliopathy.

Yosuke Ogawa, Shota Kato, Kazuhiro Shiraga

|Mar 06, 2026
BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

Kaito Mimura, Akira Kaino, Yotaro Ochi

|Feb 03, 2026
Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Tomoya Komori, Tomoko Kawai, Yusuke Okuno

|Aug 05, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Shota Kato, Kentaro Nakashima, Genki Yamato

Pageof 3

Frequent Collaborators

9 joint publications

Motohiro Kato

4 joint publications

Mitsuteru Hiwatari

3 joint publications

Junko Takita

2 joint publications

Yasuo Kubota